The use of 99mtechnetium-labeled MCP-1 to assess graft coronary artery disease in rat cardiac allografts
- 30 September 2002
- journal article
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 21 (9), 1009-1015
- https://doi.org/10.1016/s1053-2498(02)00421-7
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Cardiac Transplant VasculopathyChest, 2000
- Oxidized LDL reduces monocyte CCR2 expression through pathways involving peroxisome proliferator–activated receptor γJCI Insight, 2000
- EARLY AND LATE CHEMOKINE PRODUCTION CORRELATES WITH CELLULAR RECRUITMENT IN CARDIAC ALLOGRAFT VASCULOPATHYTransplantation, 2000
- Monocyte Chemoattractant Protein-1 but Not Tumor Necrosis Factor-α Is Correlated With Monocyte Infiltration in Mouse Lipid LesionsCirculation, 1999
- The use of technetium tc 99m annexin V for in vivo imaging of apoptosis during cardiac allograft rejectionThe Journal of Thoracic and Cardiovascular Surgery, 1998
- Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosisNature, 1998
- Cardiac Allograft VasculopathyCirculation, 1997
- Monocyte Chemotactic Protein-1 Expression Is Associated With the Development of Vein Graft Intimal HyperplasiaArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Early and persistent induction of monocyte chemoattractant protein 1 in rat cardiac allografts.Proceedings of the National Academy of Sciences, 1993
- Monocyte chemoattractant protein-1 in human atheromatous plaques.JCI Insight, 1991